help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, D. L.
Right arrow Articles by Lin, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, D. L.
Right arrow Articles by Lin, T.

Endocrinology, Vol 129, 2862-2866, Copyright © 1991 by Endocrine Society


ARTICLES

Interleukin-1 beta induces interleukin-1 alpha messenger ribonucleic acid expression in primary cultures of Leydig cells

DL Wang, ML Nagpal, JH Calkins, WW Chang, MM Sigel and T Lin
Medical Service, W. J. B. Dorn Veterans Hospital, Columbia, South Carolina 29201.

Previously, we have reported that interleukin-1 (IL-1) can modulate Leydig cell steroidogenesis. Recently, IL-1-like material has been shown to be present in the testis; however, the cellular source of this material remains unclear. In the present study we found that human recombinant IL-1 beta (1-100 ng/ml) caused dose-dependent increases in IL-1 alpha mRNA expression in Leydig cells. Similar to that reported in other tissues, IL-1 alpha mRNA from Leydig cells is mainly 2.2 kilobases. IL-1 alpha mRNA expression in Leydig cells was detectable as early as 2 h after the addition of IL-1 beta (10 ng/ml) and persisted for up to 24 h. Lipopolysaccharide also stimulated IL-1 alpha mRNA expression in these cells, but phorbol ester had no effect. Our results indicate that Leydig cells are a potential source of IL-1, which has both autocrine and paracrine effects.


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. K. O'Bryan, O. Gerdprasert, D. J. Nikolic-Paterson, A. Meinhardt, J. A. Muir, L. M. Foulds, D. J. Phillips, D. M. de Kretser, and M. P. Hedger
Cytokine profiles in the testes of rats treated with lipopolysaccharide reveal localized suppression of inflammatory responses
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1744 - R1755.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Walch and P. L. Morris
Cyclooxygenase 2 Pathway Mediates IL-1{beta} Regulation of IL-1{alpha}, -1{beta}, and IL-6 mRNA Levels in Leydig Cell Progenitors
Endocrinology, September 1, 2002; 143(9): 3276 - 3283.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
D. Zeyse, E. Lunenfeld, M. Beck, I. Prinsloo, and M. Huleihel
Induction of Interleukin-1{alpha} Production in Murine Sertoli Cells by Interleukin-1
Biol Reprod, May 1, 2000; 62(5): 1291 - 1296.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
D. Zeyse, E. Lunenfeld, M. Beck, I. Prinsloo, and M. Huleihel
Interleukin-1 Receptor Antagonist Is Produced by Sertoli Cells in Vitro
Endocrinology, April 1, 2000; 141(4): 1521 - 1527.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Hu, S. You, W. Li, D. Wang, M. L. Nagpal, Y. Mi, P. Liang, and T. Lin
Expression and Regulation of Interferon-{gamma}-Inducible Protein 10 Gene in Rat Leydig Cells
Endocrinology, August 1, 1998; 139(8): 3637 - 3645.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
L. Gnessi, A. Fabbri, and G. Spera
Gonadal Peptides as Mediators of Development and Functional Control of the Testis: An Integrated System with Hormones and Local Environment
Endocr. Rev., August 1, 1997; 18(4): 541 - 609.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Cudicini, H. Lejeune, E. Gomez, E. Bosmans, F. Ballet, J. Saez, and B. Jegou
Human Leydig Cells and Sertoli Cells Are Producers of Interleukins-1 and -6
J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1426 - 1433.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1991 by The Endocrine Society